Text full multimedia monochrome

First time here?

Find out more about how The Lecture List works.

Coronavirus situation update

Our lecture organisers may or may not have had time to update their events with cancellation notices. Clearly social gatherings are to be avoided and that includes lectures. STAY AT HOME FOLKS, PLEASE.

Help!

Find out what you can do to keep The Lecture List online

Biologically moral?

Join Dr Guy Kahane as he reviews some of the most striking findings of recent neuroscientific research on morality. Guy will end the event by considering whether this research might indeed change the way we think about ethics.


Moral philosophers have been arguing for centuries about the fundamental questions of ethics. In recent years, neuroscience has joined the debate, reporting surprising findings about the neural basis of morality, and the role of emotion in moral judgment. Some scientists predict that this research will revolutionise the practice of ethics; many ethicists think that this is confused, and that there is only one way to pursue ethics: from the philosopher’s armchair. Join Dr Guy Kahane as he reviews some of the most striking findings of recent neuroscientific research on morality, as well as intriguing findings from neuroimaging experiments. Guy will end the event by considering whether this research might indeed change the way we think about ethics.


Speaker(s):

Dr Guy Kahane | talks

 

Date and Time:

21 January 2010 at 7:00 pm

Duration:

1 hour 30 minutes

 

Venue:

The Royal Institution
21 Albemarle Street
London
W1S 4BS
020 7409 2992
http://www.rigb.org/

More at The Royal Institution...

 

Tickets:

Tickets cost £8 standard, £6 concessions, £4 Ri Members.

Available from:

For more information visit www.rigb.org or call the Events Team on 020 7409 2992 9.00am-5.00pm Monday to Friday

Register to tell a friend about this lecture.

Comments

If you would like to comment about this lecture, please register here.



 

Any ad revenue is entirely reinvested into the Lecture List's operating fund